Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jin Chai, Li Qin, Guangxin Zhang, Peiyan Hua & Chengyan Jin. (2022) Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299. Bioengineered 13:4, pages 10594-10604.
Read now
Read now
Yanjing Hu, Zhi Zhao, Gang Jin, Junhao Guo, Fangyuan Nan, Xin Hu, Yunsheng Hu & Qun Han. (2022) Long noncoding RNA regulatory factor X3- antisense RNA 1 promotes non-small cell lung cancer via the microRNA-577/signal transducer and activator of transcription 3 axis. Bioengineered 13:4, pages 10749-10764.
Read now
Read now
Xinwei Qiao & Feng Zhao. (2022) Long non-coding RNA Opa interacting protein 5-antisense RNA 1 binds to micorRNA-34a to upregulate oncogenic PD-L1 in non-small cell lung cancer. Bioengineered 13:4, pages 9264-9273.
Read now
Read now
Chun Wang & Bo Cheng. (2022) MicroRNA miR-3646 promotes malignancy of lung adenocarcinoma cells by suppressing sorbin and SH3 domain-containing protein 1 via the c-Jun NH2-terminal kinase signaling pathway. Bioengineered 13:3, pages 4869-4884.
Read now
Read now
Yue Zhang, Yue Yu, Xuchen Cao & Peng Chen. (2022) Role of lncRNA FAM83H antisense RNA1 (FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase (HS6ST2) axis. Bioengineered 13:3, pages 6476-6489.
Read now
Read now
Linwen Zeng, Shaofeng Yuan, Pengfei Zhou, Jianming Gong, Xiangdong Kong & Ming Wu. (2021) Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. Bioengineered 12:2, pages 11795-11810.
Read now
Read now
Articles from other publishers (12)
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, Maryam Abedi, Arash Matinahmadi, Yasaman Sotodeh Dokht Hosnarody, Mahdi Rezaei, Yalda Saghari, Eisa Fattah, Soheila Abdi, Maliheh Entezari, Noushin Nabavi, Mohsen Rashidi, Rasoul Raesi & Afshin Taheriazam. (2023) miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response. Pathology - Research and Practice 251, pages 154906.
Crossref
Crossref
Eleonora A. Braga, Marina V. Fridman, Alexey M. Burdennyy, Vitaly I. Loginov, Alexey A. Dmitriev, Irina V. Pronina & Sergey G. Morozov. (2023) Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks. International Journal of Molecular Sciences 24:17, pages 13617.
Crossref
Crossref
Kajetan Kiełbowski, Konrad Ptaszyński, Janusz Wójcik & Małgorzata Edyta Wojtyś. (2023) The role of selected non-coding RNAs in the biology of non-small cell lung cancer. Advances in Medical Sciences 68:1, pages 121-137.
Crossref
Crossref
Shirin Azizidoost, Farhoodeh Ghaedrahmati, Mohadeseh Sheykhi-Sabzehpoush, Shahab Uddin, Mehri Ghafourian, Abdolah Mousavi Salehi, Mona Keivan, Maryam Cheraghzadeh, Zahra Nazeri, Maryam Farzaneh & Seyed Esmaeil Khoshnam. (2022) The role of LncRNA MCM3AP-AS1 in human cancer. Clinical and Translational Oncology 25:1, pages 33-47.
Crossref
Crossref
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Mohammad Taheri & Mohammad Samadian. (2022) A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression. Cancer Cell International 22:1.
Crossref
Crossref
Liangyin Fu, Guangming Zhang, Yongfeng Wang, Tingting Lu, Bin Liu, Yajun Jiao, Haizhong Ma, Shixun Ma, Kehu Yang & Hui Cai. (2022) The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis. Disease Markers 2022, pages 1-16.
Crossref
Crossref
Qi Xu, Jia-Lin Xu, Wen-Quan Chen, Wen-Xiu Xu, Yu-Xin Song, Wen-Juan Tang, Di Xu, Meng-Ping Jiang & Jinhai Tang. (2022) Roles and mechanisms of miR-195–5p in human solid cancers. Biomedicine & Pharmacotherapy 150, pages 112885.
Crossref
Crossref
Anetta Sulewska, Jacek Niklinski, Radoslaw Charkiewicz, Piotr Karabowicz, Przemyslaw Biecek, Hubert Baniecki, Oksana Kowalczuk, Miroslaw Kozlowski, Patrycja Modzelewska, Piotr Majewski, Elzbieta Tryniszewska, Joanna Reszec, Zofia Dzieciol-Anikiej, Cezary Piwkowski, Robert Gryczka & Rodryg Ramlau. (2022) A Signature of 14 Long Non-Coding RNAs (lncRNAs) as a Step towards Precision Diagnosis for NSCLC. Cancers 14:2, pages 439.
Crossref
Crossref
Wen Wang, Hao Bo, Yumei Liang & Guoli Li. (2022) LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma. Frontiers in Endocrinology 12.
Crossref
Crossref
Guojie Chen, Kai Wang, Guoshu Li, Leidong Wang, Yangyang Xiao & Bo Chen. (2021) Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 28:9, pages 945-959.
Crossref
Crossref
Xiao Yu, Qingyuan Zheng, Qiyao Zhang, Shuijun Zhang, Yuting He & Wenzhi Guo. (2021) MCM3AP-AS1: An Indispensable Cancer-Related LncRNA. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
HUALIANG LV, CHANGCHUN LAI, WENQU ZHAO & YIBO SONG. (2021) GABPB1-AS1 acts as a tumor suppressor and inhibits non-small cell lung cancer progression by targeting miRNA-566/F-box protein 47. Oncology Research 29:6, pages 401-409.
Crossref
Crossref